Cardiac metastasis of small cell lung cancer diagnosed with PET/CT and echocardiography

Volume: 55 Number: 3 September 1, 2016
  • Fırat Uygur
  • Hakan Tanrıverdi
  • Bülent Altınsoy
  • Fatma Erboy
  • Ziyaeddin Aktop
  • Meltem Tor
EN TR

Cardiac metastasis of small cell lung cancer diagnosed with PET/CT and echocardiography

Abstract

Cardiac metastases of malignant tumors occur more frequently than primary tumors of the heart. Local invasion of the pericardium and heart is commonly seen in primary lung cancer, but myocardial metastasis without local invasion rarely occurs. 18-F fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is widely used in the diagnostic evaluation and staging of different malignant tumors, but the FDG uptake of myocardium is intense and heterogeneous. A-55-year old male smoker was diagnosed with small cell lung cancer (SCLC) by bronchoscopic biopsy, and FDG PET/CT showed high FDG uptake in myocardium. Transthoracic echocardiagraphy revealed mass like lesions in the apical regions of both ventricules. After systematic evaluation of imaging studies, the mass was diagnosed as intracardiac metastasis of SCLC and histopathologic examination. This case shows that intracardiac metastases of malignant tumors can be seen without local invasion, and FDG PET/CT can be a useful diagnostic tool in evaluation of intracardiac metastasis.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Fırat Uygur

Hakan Tanrıverdi

Bülent Altınsoy

Fatma Erboy

Ziyaeddin Aktop

Meltem Tor

Publication Date

September 1, 2016

Submission Date

September 1, 2016

Acceptance Date

-

Published in Issue

Year 2016 Volume: 55 Number: 3

Vancouver
1.Fırat Uygur, Hakan Tanrıverdi, Bülent Altınsoy, Fatma Erboy, Ziyaeddin Aktop, Meltem Tor. PET/BT ve ekokardiografi ile tanı konan küçük hücreli akciğer kanserinin kardiyak metastazı. EJM. 2016 Sep. 1;55(3):149-51. doi:10.19161/etd.344214

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.